MTHFR Gene Mutation and BII — What It Means for Your Recovery
In this segment, Dr. Robert Whitfield MD explains that the MTHFR gene mutation has become the most significant genetic factor affecting his microsurgical practice, particularly due to its association with clotting risk—a link that was previously unrecognized compared to established thrombophilic conditions such as antiphospholipid syndrome and protein C and S deficiencies. He emphasizes that as knowledge of single‑nucleotide polymorphisms expands, clinicians gain better insight into patient behavior, detoxification capacity, and recovery trajectories. Dr. Whitfield also shares his professional evolution toward solo private practice, which sparked a deeper interest in genetics, functional nutrition, food‑sensitivity testing, gut health assessments, and ultimately toxicity‑burden testing as complementary tools for optimizing patient outcomes.
